Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"
topic_facet:"Multicenter Study"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&lookfor=%22Dexamethasone%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&lookfor=%22Dexamethasone%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Journal+of+clinical+oncology+%3A+official+journal+of+the+American+Society+of+Clinical+Oncology%22&filter%5B%5D=topic_facet%3A%22Multicenter+Study%22&lookfor=%22Dexamethasone%22&type=Subject
PubPharm (87)
1
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2024
von
Leypoldt, L.
|
Tichy, D.
|
Besemer, B.
| +24
Wird geladen...
2
Daratumumab, Cyclophosphamide, Bortezomib, Lenalidomide, and Dexamethasone as Induction and Extended Consolidation Improves Outcome in Ultra-High-Risk Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Kaiser, M.
|
Hall, A.
|
Walker, K.
| +17
Wird geladen...
3
Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR) : A Randomized, Open-Label, Phase III Trial
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Sonneveld, P.
|
Chanan-Khan, A.
|
Weisel, K.
| +16
CommentIn: J Clin Oncol. 2023 May 10;41(14):2668. - PMID 36940403
Wird geladen...
4
Overall Survival With Daratumumab, Lenalidomide, and Dexamethasone in Previously Treated Multiple Myeloma (POLLUX) : A Randomized, Open-Label, Phase III Trial
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2023
von
Dimopoulos, M.
|
Oriol, A.
|
Nahi, H.
| +19
Wird geladen...
5
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Costa, L.
|
Chhabra, S.
|
Medvedova, E.
| +14
Wird geladen...
6
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia : Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Kersten, M.
|
Amaador, K.
|
Minnema, M.
| +15
Wird geladen...
7
Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2021
von
Bahlis, N.
|
Baz, R.
|
Harrison, S.
| +12
Wird geladen...
8
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2021
von
Sonneveld, P.
|
Dimopoulos, M.
|
Beksac, M.
| +37
Wird geladen...
9
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma : The Hovon 143 Study
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2021
von
Stege, C.
|
Nasserinejad, K.
|
van der Spek, E.
| +22
Wird geladen...
10
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2021
von
Richardson, P.
|
Kumar, S.
|
Masszi, T.
| +19
CommentIn: J Clin Oncol. 2021 Aug 1;39(22):2423-2425. - PMID 34111942
Wird geladen...
1
2
3
4
5
6
7
8
9
Nächster »
[9]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Filter aufheben
Thema: Multicenter Study
Medienart
87
Aufsätze
56
E-Artikel
56
E-Ressourcen
31
Gedruckte Aufsätze
Zeitschriftentitel
Journal of clinical oncology : official journal...
Thema
87
7S5I7G3JQL
87
Dexamethasone
87
Journal Article
Multicenter Study
59
Research Support, Non-U.S. Gov't
51
Randomized Controlled Trial
35
Klinische Studie
26
8N3DW7272P
26
Cyclophosphamide
24
Clinical Trial, Phase III
24
Comparative Study
22
69G8BD63PP
22
Bortezomib
22
Clinical Trial, Phase II
19
Antiemetics
18
80168379AG
18
Doxorubicin
16
5J49Q6B70F
16
Cisplatin
16
Q20Q21Q62J
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
56
2000-
16
1900-1999
Erscheinungsjahr(e)
Von:
Bis:
Sprache
87
Englisch
Haven't found what you're looking for?
Wird geladen...